Glaukos Corporation · 1 week ago
Key Accounts Director
Glaukos Corporation is seeking a Key Accounts Director to drive strategic growth of their products within national and regional accounts. This role involves building C-suite-level relationships, leading contract negotiations, and collaborating cross-functionally to support product adoption and future pipeline introductions.
Health CareMedicalWellness
Responsibilities
Build and expand long-term executive-level relationships with national, regional, and private equity partners
Develop and implement account strategies to achieve performance goals
Negotiate, execute, and manage contracts to drive product integration and pull-through
Collaborate with internal stakeholders (Corporate Accounts, Private Equity, Sales, Market Access, Medical, Marketing, Finance, Legal, GPS) to align on growth initiatives
Identify synergies that connect brand priorities with account strategies
Maintain deep knowledge of payer dynamics, reimbursement trends, and distribution channels
Share market insights and emerging trends with internal teams to support strategy development
Attend relevant industry and customer meetings
Demonstrate a high level of agility, persistence, and execution in a fast-paced and ambiguous environment
Ensure all activities comply with corporate, regulatory, and legal standards
Qualification
Required
Bachelor's degree
8+ years in complex, customer-facing roles within the pharmaceutical, ophthalmology, medical device, or similar sectors, including reimbursement experience
4+ years managing large national accounts and/or private equity partnerships
Proven success in contract negotiation and business development
Strong strategic, communication, and relationship-building skills across all organizational levels
Experience working cross-functionally with teams such as marketing, sales, and market access
Ability to travel, including overnight stays (~60%)
Preferred
Channel distribution experience
Experience in strategy or corporate development within medical device or pharma
Experience partnering with ACOs, IDNs, National Management Companies, and health systems
Benefits
$80K variable comp
RSUs
Company
Glaukos Corporation
At Glaukos, our focus is to develop and lead the global ophthalmic market with novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases—therapies that advance the existing standard of care and enrich the lives and treatment alternatives for patients worldwide.
Funding
Current Stage
Public CompanyTotal Funding
$121MKey Investors
Meritech Capital PartnersOrbiMed
2015-06-25IPO
2013-02-07Series F· $30M
2012-10-03Debt Financing· $6M
Leadership Team
Recent News
thefly.com
2026-01-16
Company data provided by crunchbase